904.3000 2.95 (0.33%)
NSE Oct 01, 2025 15:31 PM
Volume: 38,869
 

Motilal Oswal
Gross margin contracted by 390bp YoY to 71% in 1QFY22 due to increased competition in certain products. EBITDA margin contracted at a higher rate of 1,260bp YoY to 17.8% (est. 25.4%) due to higher operational cost (other...
Number of FII/FPI investors decreased from 198 to 192 in Jun 2025 qtr
More from Alembic Pharmaceuticals Ltd.
Recommended